TNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1

NCT00089700 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
80
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tanox